⌘K

Login Start Free

Home/Filings/4/0001415889-22-001330

4//SEC Filing

Amin Biren 4

Accession 0001415889-22-001330

CIK 0001790340other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:35 PM ET

Size

5.3 KB

Accession

0001415889-22-001330

Insider Transaction Report

Form 4

Period: 2022-02-10

Immuneering CorpIMRX

CFO, TREASURER

Transactions

Award
Stock Option
2022-02-10+70,050→ 70,050 total
Exercise: $9.66Exp: 2032-02-09→ Class A Common Stock (70,050 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.

Documents

1 file

4
form4-02142022_020254.xmlPrimary

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1

filerCIK 0001870127

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 5:35 PM ET
Size: 5.3 KB

View on SEC.gov